Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omeros Corporation - Common Stock (NQ:OMER)

13.24 -0.01 (-0.08%)
Streaming Delayed Price Updated: 11:30 AM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 314,558
Open 13.36
Bid (Size) 13.23 (300)
Ask (Size) 13.25 (300)
Prev. Close 13.25
Today's Range 13.00 - 13.40
52wk Range 3.890 - 17.65
Shares Outstanding 62,855,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
From Omeros Corporation
Via Business Wire
News headline image
CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®
From Omeros Corporation
Via Business Wire

Performance

YTD
-19.2%
-19.2%
1 Month
+28.8%
+28.8%
3 Month
-7.8%
-7.8%
6 Month
+17.2%
+17.2%
1 Year
+219.8%
+219.8%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporation - OMER
From Pomerantz LLP
Via GlobeNewswire
Omeros Corp (NASDAQ:OMER) Swings to Profit on YARTEMLEA Launch, Topping EPS Forecasts ↗
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
From Pomerantz LLP
Via GlobeNewswire
News headline image
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
From Pomerantz LLP
Via GlobeNewswire
News headline image
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Which stocks are moving on Friday? ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Friday's session. ↗
Via Chartmill
Top movers in Friday's pre-market session ↗
Via Chartmill
News headline image
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
From Omeros Corporation
Via Business Wire
News headline image
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Omeros Announces Webcast Details for Annual Meeting of Shareholders
From Omeros Corporation
Via Business Wire
News headline image
Omeros (OMER) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Topics Derivatives
News headline image
Omeros (OMER) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Omeros Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Omeros Corporation Reports First Quarter 2026 Financial Results
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
From Omeros Corporation
Via Business Wire
News headline image
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
From Sagimet Biosciences Inc.
Via GlobeNewswire
News headline image
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
From Omeros Corporation
Via Business Wire
These stocks are gapping in today's session ↗
Via Chartmill

Frequently Asked Questions

Is Omeros Corporation - Common Stock publicly traded?
Yes, Omeros Corporation - Common Stock is publicly traded.
What exchange does Omeros Corporation - Common Stock trade on?
Omeros Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Omeros Corporation - Common Stock?
The ticker symbol for Omeros Corporation - Common Stock is OMER on the Nasdaq Stock Market
What is the current price of Omeros Corporation - Common Stock?
The current price of Omeros Corporation - Common Stock is 13.24
When was Omeros Corporation - Common Stock last traded?
The last trade of Omeros Corporation - Common Stock was at 08/10/26 11:30 AM ET
What is the market capitalization of Omeros Corporation - Common Stock?
The market capitalization of Omeros Corporation - Common Stock is 832.21M
How many shares of Omeros Corporation - Common Stock are outstanding?
Omeros Corporation - Common Stock has 832M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.